Conversion to aflibercept for chronic refractory or recurrent neovascular age-related macular degeneration.
暂无分享,去创建一个
Ivana K. Kim | Joan W. Miller | J. Loewenstein | L. Sobrin | D. Eliott | D. Vavvas | John B. Miller | Y. Yonekawa | C. Andreoli
暂无分享,去创建一个
Ivana K. Kim | Joan W. Miller | J. Loewenstein | L. Sobrin | D. Eliott | D. Vavvas | John B. Miller | Y. Yonekawa | C. Andreoli